A carregar...

Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial

OBJECTIVE: No therapy is known to improve health-related quality of life (HRQL) or dyspnoea in patients with idiopathic pulmonary fibrosis (IPF). This study investigated longitudinal changes in HRQL and dyspnoea and explored the effects of bosentan on these endpoints during the BUILD-1 trial. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Raghu, Ganesh, King, Talmadge E, Behr, Juergen, Brown, Kevin K, du Bois, Roland M, Leconte, Isabelle, Roux, Sébastien, Swigris, Jeff
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848824/
https://ncbi.nlm.nih.gov/pubmed/19679600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00188108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!